AS THE US biotechnology industry matures,biotech com panies are approaching profit ability based on growing product revenues,positive financing and major M&A activity in 2006.The key driver behind the industry's success in financial performance,financing and deals is its accomplishments in product commercializations," says Ernst & Young,which recently released its 2007 global biotechnology report.
展开▼
